AEE788

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AEE788, covering 2012-01-09 to 2015-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]